Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Research Fellow at Dana-Farber Cancer Institute, shared a post on X by Kelly Shanahan, Director of METAvivor Research and Support, adding:
“Nice to see our ADC toxicity review highlighted at MASCC25!”
Quoting Kelly Shanahan’s post:
“With ADCs, the same antibody or same payload in different combos can cause different toxicities.”
Title: Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Authors: Paolo Tarantino, Biagio Ricciuti, Shan M. Pradhan, Sara M. Tolaney
You can read the Full Article in Nature Reviews Clinical Oncology.
More posts featuring Paolo Tarantino and Kelly Shanahan.